Perioperative Respiratory Adverse Events

3

Review clinical trials related to Perioperative Respiratory Adverse Events. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

PRAE and Asymptomatic and Symptomatic URI Patients

The objective of this study is to determine the prevalence of asymptomatic viral carriers among healthy surgical patients and to describe the demographic and clinical characteristics of these patients. The secondary objective is to compare the incidence of perioperative respiratory adverse events (PRAE) between virus positive patients with and without upper respiratory infection (URI) symptoms. The secondary objective would aim to enroll patients who report recent URI symptoms.

Participants needed: 300
Trial details
Age: 0-18Biological sex: AllType: ObservationalSponsor: Brittany WillerUpdated: Sep 14, 2026
Eligibility criteria

Patients <18 years of age presenting for elective ambulatory procedures under ge...

Chronic medical problems (excluding asthma), diagnosis of cancer, transplant rec...

Status: Recruiting

Nasal Decongestant to Reduce Perioperative Adverse Events in Children With Upper Respiratory Track Infections Having Anesthesia.

The goal of this multicentre, double-blind, randomised controlled trial study is to learn if the use of a nasal spray to open the nasal passages and increase airflow before surgery can reduce the occurrence of perioperative respiratory adverse events in children with upper respiratory tract infection who are undergoing anesthesia. The main questions it aims to answer are: * Does use of a nasal decongestant (Oxymetazoline 0.05%) reduce perioperative respiratory adverse events during emergence (when waking up from anesthesia) or in the post-anesthesia care unit in children. * Is it easy and acceptable to doctors, children and parents to use the nasal decongestant treatment? Researchers will compare the nasal decongestant to a placebo (a look-alike substance that contains no drug) to see if it works to reduce perioperative respiratory adverse effects. Participants will: * Take a nasal decongestant or a placebo prior to surgery (just before anaesthesia is given) * Be monitored during and after surgery in the post-anaesthesia care unit for any perioperative respiratory adverse events. * Be asked about how acceptable they found the treatment.

Participants needed: 200
Trial details
Phase: Phase 4Age: 1-8Biological sex: AllType: InterventionalSponsor: Telethon Kids InstituteUpdated: Nov 19, 2025Locations: 1
Eligibility criteria

Children aged 1 to 8.99 years with a current or recent upper respiratory tract i... [+1]

Currently taking nasal decongestants (past 24 hours) or receiving co-phenylocain... [+8]

Status: Not yet recruiting

Lateral Positioning for Extubation After Adenotonsillectomy

The postoperative recovery period following general anesthesia has been associated with a 30%-50% incidence of postoperative respiratory adverse events (PRAEs) in pediatric populations, including laryngospasm, airway obstruction, and hypoxemia. Despite the limited effects of existing pharmacological and operative interventions, positional optimization (e.g., lateral or semirecumbent position) may play a potential role by decreasing airway resistance and improving oxygenation. However, evidence-based evidence for its use in pediatric populations is still lacking, necessitating the urgent need for randomized controlled trials.

Participants needed: 350
Trial details
Age: 1-6Biological sex: AllType: InterventionalSponsor: Sichuan UniversityUpdated: Aug 6, 2025Locations: 1
Eligibility criteria

Subjects aged 1-6 years old without gender limit. [+3]

Presence of concomitant cardiac or pulmonary dysfunction or other significant sy... [+4]